We are excited to share with you our vision to spread an eye-tracking solution that offers clinical evaluation in a wink. We want to show you an innovation that aims to disrupt the current clinical practice of neurologists. See you soon in San Diego!
neuroClues™, biomarkers in a blink. In a world where neurological disorders will affect 1 person in 3 and where the number of Parkinson’s patients will double in the next decade, reaching 13 million patients, neuroClues' mission is to empower clinicians with biomarkers that allow them to identify neurological disorders (Parkinson’s Disease, Alzheimer’s Disease, and Multiple Sclerosis) years before visible symptoms.
Brands: NeuroClues™ brings the wealth of eye-tracking research to the clinic, helping objectively diagnose neurological diseases earlier. It provides non-invasive, quick, and robust biomarkers to assess clinical evaluation in a wink.